Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Pharmacol Res. 2017 Jan 25;119:89–98. doi: 10.1016/j.phrs.2017.01.024

Fig. 1. Cytotoxicity of cabozantinib in parental cell lines and drug resistant cell lines.

Fig. 1

(A) Structure of cabozantinib. (B) Cytotoxicity of cabozantinib in H460 and H460/MX20 cells. (C) Cytotoxicity of cabozantinib in HEK293/pcDNA3.1, ABCG2-482-R2, ABCG2-482-G2, ABCG2-482-T7 cells.